Published in Cardiovasc Hematol Agents Med Chem on January 01, 2010
Estrogen and mitochondria function in cardiorenal metabolic syndrome. Prog Mol Biol Transl Sci (2014) 0.79
Late gestational hypoxia and a postnatal high salt diet programs endothelial dysfunction and arterial stiffness in adult mouse offspring. J Physiol (2015) 0.77
Early parenthood as a link between childhood disadvantage and adult heart problems: A gender-based approach. Soc Sci Med (2016) 0.75
Lean Body Mass as a Predictive Value of Hypertension in Young Adults, in Ankara, Turkey. Iran J Public Health (2015) 0.75
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science (2005) 9.80
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature (2000) 7.03
Molecular determinants for the tissue specificity of SERMs. Science (2002) 6.20
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med (2006) 6.14
Estrogen receptors: how do they signal and what are their targets. Physiol Rev (2007) 5.27
Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology (2004) 5.20
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
Molecular and cellular basis of cardiovascular gender differences. Science (2005) 4.37
Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev (2004) 3.74
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med (2002) 3.68
Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol (2002) 3.65
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem (2000) 3.34
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol (2007) 3.19
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 3.03
Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol (2006) 2.90
Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv (2003) 2.88
COX-2-derived prostacyclin confers atheroprotection on female mice. Science (2004) 2.87
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.80
Extranuclear steroid receptors: nature and actions. Endocr Rev (2007) 2.72
Androgens and cardiovascular disease. Endocr Rev (2003) 2.71
Production and actions of estrogens. N Engl J Med (2002) 2.66
Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol (2004) 2.58
Vascular actions of estrogens: functional implications. Pharmacol Rev (2008) 2.52
Role of estrogen receptor beta in estrogen action. Annu Rev Physiol (2001) 2.40
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun (2005) 2.37
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology (2007) 2.29
Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol (2003) 2.17
Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett (2004) 2.17
Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res (2002) 2.05
Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem (2000) 2.00
Endogenous estrogens influence endothelial function in young men. Circ Res (2003) 1.98
Estrogen receptor beta: an overview and update. Nucl Recept Signal (2008) 1.97
Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology (1999) 1.93
Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res (2001) 1.91
Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab (2000) 1.88
The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids (2005) 1.83
Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med (2006) 1.80
G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun (2006) 1.79
G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology (2008) 1.79
Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol (2006) 1.77
ERbeta has nongenomic action in caveolae. Mol Endocrinol (2002) 1.73
Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res (2000) 1.72
Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation (2000) 1.71
Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res (1999) 1.68
Dietary phytoestrogens and health. Phytochemistry (2004) 1.67
Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol (2003) 1.66
Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension (2007) 1.64
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Circulation (2002) 1.57
Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding. Endocrinology (2006) 1.57
Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol (2001) 1.52
Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem Pharmacol (2005) 1.52
Discovery of three novel G-protein-coupled receptor genes. Genomics (1998) 1.50
Minireview: estrogen receptor-mediated rapid signaling. Endocrinology (2006) 1.49
Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res (2002) 1.49
Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology (1999) 1.49
Signaling by estrogens. J Cell Physiol (2007) 1.48
Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol (2002) 1.43
Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem (2005) 1.41
Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Am J Med (2005) 1.40
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab (2007) 1.38
Ageing and vascular ageing. Postgrad Med J (2006) 1.36
Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol (2006) 1.35
Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br J Pharmacol (1991) 1.35
Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health. Biotechnol J (2007) 1.35
Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci (1999) 1.34
Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas (1995) 1.33
Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol (1997) 1.32
Antagonistic effects of 17 beta-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol (1999) 1.32
Gender-specific inhibition of Ca2+ entry mechanisms of arterial vasoconstriction by sex hormones. Clin Exp Pharmacol Physiol (1999) 1.30
Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res (2002) 1.29
New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab (2003) 1.27
Role of female sex hormones in the development and reversal of dahl hypertension. Hypertension (2000) 1.27
Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation (1999) 1.26
Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations. Hypertension (2004) 1.24
Genomic and non-genomic effects of estrogens on endothelial cells. Steroids (2004) 1.20
Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res (1999) 1.18
Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol (1999) 1.17
Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta (2006) 1.16
Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation (2000) 1.16
17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol (1994) 1.16
Clinical practice. Postmenopausal hormone-replacement therapy. N Engl J Med (2001) 1.15
Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci (2007) 1.15
17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol (2004) 1.14
Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension (1995) 1.13
Gender differences in coronary artery diameter reflect changes in both endothelial Ca2+ and ecNOS activity. Am J Physiol (1999) 1.12
Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc (2006) 1.12
Lessons learnt from structural studies of the oestrogen receptor. Best Pract Res Clin Endocrinol Metab (2006) 1.10
Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther (1999) 1.09
Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle. Am J Physiol Cell Physiol (2001) 1.07
17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta (1998) 1.07
Gender-specific reduction in contractility and [Ca(2+)](i) in vascular smooth muscle cells of female rat. Am J Physiol Cell Physiol (2000) 1.05
Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol (2000) 1.04
17beta-estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol (2000) 1.03
A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab (2001) 1.03
Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol (2002) 1.02
Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci U S A (1999) 1.02